31.07.2024
2 min
1851
Artificial intelligence is changing the way modern medicine works, making clinical coding accurate, fast, and automated. Thanks to AI, machine learning, and natural language processing technologies, clinics are moving from manual data entry to autonomous analytics systems that recognize diagnoses, procedures, and research results in real time. The development of the clinical coding market is shaping a new era of digital health, where data accuracy and standardization affect the quality of treatment, financial efficiency, and global medical statistics. The article reveals the main technologies, companies, and investment trends that are defining the future of autonomous coding in the US, Europe, and the world.
Not so long ago, medical coding seemed like a technical, secondary process that was performed manually, mostly in accounting or medical statistics departments. But over the past few years, this industry has undergone a radical transformation. The combination of electronic health records (EHR), global disease classifications, and artificial intelligence technologies has turned coding into a critically important element of digital medicine.
In modern clinics, coding is not only the basis for correct billing or reporting to insurance companies. It is the basis for medical analytics, disease statistics, scientific research, forecasting the burden on the healthcare system, and even modeling government treatment programs. Each correctly recorded code is not just a number in a database, but a part of a person’s medical history that enters a global knowledge system.
That is why with the advent of automated solutions based on AI and ML, the industry has received a new impetus for development. Algorithms now not only suggest codes to doctors or verify them, but also train on millions of records, revealing patterns that remained unnoticed by humans. Artificial intelligence is able to identify combinations of symptoms that were previously missed, optimize billing and even predict possible medical errors.
The Global Clinical Coding Assistance Software Market Research 2023 report allows you to understand the scale of these changes. This detailed study, conducted on 19 pages, describes 15 leading companies in the industry, analyzes their technologies, sales models, marketing approaches, geographical coverage, as well as key trends until 2031. And most importantly, it shows that clinical coding is gradually becoming a fully autonomous process, where the role of humans is reduced to quality control and training of systems.
Over the past decade, the clinical coding market has transformed from a niche segment into one of the most dynamic areas of medical technology. While in 2015, most medical institutions around the world still relied on manual coding, today more than 80% of large clinics have integrated at least partial automation of the process.
According to GlobeNewswire, the global medical coding market will reach $47.75 billion by 2031, growing at a rate of 10.9% per year. But the Computer-Assisted Coding (CAC) segment is showing even more impressive rates – according to Verified Market Research and Mordor Intelligence, its volume will increase from $4.65 billion in 2022 to $11.1 billion in 2030. These numbers are not just statistics: they reflect fundamental changes in the organization of medical processes.
Traditionally, the main barrier to automation has been the heterogeneity of medical data. Different countries have their own reporting standards, classification systems, and medical record languages. However, with the spread of ICD-11, as well as the transition of hospitals to electronic medical records, the entire system is gradually being unified. For the first time in history, global exchange of structured data is becoming possible – and this is where the need for flexible, intelligent coding systems arises.
The main drivers of market growth today can be clearly divided into several groups:
Technological factors. The rapid development of AI, NLP, and cloud services has simplified the implementation of automated solutions in clinics of all sizes.
Regulatory initiatives. Governments in most countries encourage the digitalization of healthcare through grants and mandatory reporting standards.
Economic incentives. Automation reduces the cost of manual coding, minimizes errors, and speeds up the payment of insurance claims.
Demographic trends. As the number of patients increases and the population ages, the volume of data increases exponentially, making manual processing impossible.
Each of these factors reinforces the others, creating an avalanche effect. As a result, clinical coding is moving from an auxiliary function to a key element of data management in medicine. CAC systems are already used in telemedicine, laboratory analytics, and even pharmacovigilance, where the speed of processing records is critical.
The US remains the absolute center of gravity for the entire clinical coding industry. It combines three main factors: the most developed insurance system in the world, a huge amount of medical data and a culture of innovation in the field of HealthTech.
In 2022, the medical coding market in the US amounted to $ 18.6 billion, and according to Market.us, it will reach $ 44 billion by 2032. This is not just a growth in money – it is an indicator of the depth of integration of digital technologies into medicine. Already, over 88% of doctors in the US use electronic medical records, which creates a favorable environment for the implementation of AI systems.
Before diving into the details, it is important to outline which market segments are shaping the American clinical coding model:
ICD segment — about 65% in the market revenue structure;
Outsourcing of services — about 70% in 2022, with a growth rate of 8.4%;
Medical specialties outside the main categories — almost half of the market (49%);
The number of coding specialists will grow by 7% by 2031, according to the forecast of the US Bureau of Labor.
These data indicate that the demand for automated tools in the US is supported not only by the market size, but also by human resources: there is a shortage of specialists, and the volume of documentation is growing. Therefore, companies are massively switching from manual code entry to systems where AI and humans work together.
It is important that in the US, it is commercial players (such as 3M, Optum, Nuance) that determine the vector of development. They do not just sell software, but create entire platforms integrated with insurance services and hospital databases. Such a model contributes to the standardization of the market and accelerates the exchange of information between different medical institutions.
The US can be considered a testing ground where all the main innovations in clinical coding are tested – from autonomous coding to treatment quality analytics. And the experience gained here will become the basis for global standards in the coming years.
The European clinical coding segment is evolving in a more regulated environment, where government digitalization programs play a major role. According to Market Data Forecast, the market was valued at $5.91 billion in 2023 and is expected to grow to $10.03 billion by 2028, exhibiting a CAGR of 11.16%.
Despite being smaller in scale than the US, Europe is characterized by a high level of technological maturity and data security requirements. Each country has its own strategy, but several trends remain common.
The following are the key features that determine the development of the clinical coding market in Europe:
Dominance of the ICD classification. Local versions of the standard (ICD-10-AM, ICD-10-CM, etc.) have become the basis for all national systems.
A large role of outsourcing companies. Due to a shortage of specialists, public hospitals often outsource the processing of codes to external contractors.
The leading markets are the United Kingdom and Germany. This is where most of the university hospitals and medical centers that set the standards are concentrated.
EU regulatory support. The eHealth Digital Service Infrastructure and Horizon Europe programs fund the creation of common databases.
Increased emphasis on the protection of personal data. GDPR has become not only a legal norm, but also a business factor that influences the choice of technologies.
This approach makes the European market more stable, but less flexible. Solutions are implemented more slowly, but have a higher level of trust from government agencies and patients.
At the same time, European countries are increasingly cooperating with each other: common data centers, cloud storage, standards for exchanging medical records are being created. This is a prerequisite for the widespread use of autonomous coding systems in the coming years.
The investment landscape of the clinical coding market is a kind of map of the development of HealthTech as an industry. It is funding that determines which products will survive, which companies will become global, and which will remain local service providers.
According to PitchBook, there are more than 335 companies involved in the development of clinical coding software in the world. The vast majority of them — 295 — are based in North America, which is explained by the concentration of venture capital and the presence of large customers among American hospital chains. However, it is worth emphasizing: the development of the industry is not only taking place in the USA.
For a deeper analysis, the researchers selected 15 companies with the largest investments. All of them have one thing in common — they develop their own software, and not just offer coding services. This means that they are the ones creating the intellectual core of the market.
To assess the scale, let’s consider a brief cross-section of the main players:
3M Codefinder (USA) — over $15.7 billion; an industry pioneer who integrated code grouping and auditing algorithms back in the 1990s.
Nuance Clintegrity (USA) — $4.33 billion, the first company to combine medical coding and speech recognition.
TruCode Encoder (USA) — $74.8 million, focused on a solution for small and medium-sized clinics.
Optum (USA/Ireland/UK) — a multi-disciplinary corporation with its own CAC and analytics platform.
Carepatron (New Zealand) — a new player offering simple AI solutions for private practices.
On average, it takes about five years from the moment of foundation to the first investment round, which is a very short cycle for medical software. This means that the market is extremely “hot”: investors understand the prospects and are not afraid of risk.
In total, 10 out of 15 companies raised more than $20.3 billion, the average investment is $2 billion, and the size of the round is $28.36 million. This concentration of capital shows that clinical coding has ceased to be an “auxiliary” segment and has become an independent branch of digital medicine.
Of particular interest is the emergence of new startups in Europe and Asia that are focused not on large hospitals, but on niche solutions – mobile applications for clinical trials, automatic billing, coding of test results. This indicates that the market is going beyond hospitals, forming an entire ecosystem of B2B services for various medical chains.
If you look deeper, it becomes clear: technology is at the heart of the entire clinical coding market. The algorithms a company uses determine recognition accuracy, processing speed, security level and, ultimately, customer trust.
According to industry research, 11 out of 15 companies openly declare the use of artificial intelligence, and the rest also integrate elements of automation.
The current technology stack looks like this:
AI (Artificial Intelligence) is the main driver that allows you to analyze texts, bills, appointments and automatically assign codes.
NLP/NLU (Natural Language Processing / Understanding) are systems that understand the language of doctors and convert free text into structured data.
ML (Machine Learning) provides self-learning of the system based on real cases and audit checks.
ASR (Automatic Speech Recognition) is a function that allows the doctor to dictate records by voice, and the system generates the code itself.
Cloud technologies (AWS, Azure, GCP) provide scalability, stability and speed of updates.
Before the advent of modern CAC systems, coding was tied to local servers and required complex IT infrastructure. Now, most companies have switched to cloud services, which allowed customers to avoid equipment costs and simplified deployment.
Additionally, the market is moving towards interoperability, i.e. compatibility with other medical platforms – EHR, laboratory databases, insurance APIs. Companies that are the first to ensure full interaction will gain a significant competitive advantage.
In the future, deeper integration of generative AI models is expected, capable not only of coding records, but also of analyzing the context of treatment. Such systems will be able to automatically offer clarifications to the doctor, predict risks or remind about necessary procedures. This is no longer just coding – it is the beginning of intelligent support for medical decisions.
The financial architecture of the clinical coding market largely determines its accessibility for different types of healthcare facilities. Most software vendors follow the Software as a Service (SaaS) model, which allows for flexible scaling of the number of users and modules.
To understand how prices are formed, it is enough to look at the typical tariff structure used by leading companies. Below are three main approaches:
Individual subscription per user. The cost ranges from $76 to $684 per year and is suitable for small clinics or private doctors.
Corporate subscription for organizations. On average, it is $5.1–44.3 thousand dollars per year, depending on the number of patients and available modules.
Annual maintenance for hospitals. Provides full support, updates and audits, costs about $44 thousand per year.
Such packages are usually supplemented by three license levels – Basic, Professional and Enterprise. Each level opens up new features – from simple code search to automatic billing, auditing and integration with EHR.
Most providers prefer not to publish exact prices, leaving room for negotiation. This allows you to adapt the cost to a specific client – for example, large hospitals receive discounts for the number of users, while private clinics can pay in installments.
At the same time, the SaaS model creates a customer retention effect: once a hospital has already configured processes for a certain system, it is expensive for it to switch to another. That is why CAC companies focus not only on sales, but also on long-term service – support, updates, staff training.
As a result, business models in the field of clinical coding are becoming more similar to models in the field of corporate IT: subscription, analytics, consulting. But with the difference that here the cost of a mistake is measured not only in money, but also in the health of patients.
In the 2020s, the clinical coding market ceased to be purely technological – it entered a phase of open competition for recognition and trust. Marketing has become no less important than the development of algorithms. In this industry, customers are not random buyers, but hospitals, clinics, research institutes that make decisions for years to come. Therefore, the presence on the network determines how quickly the company will be able to scale.
Traffic analysis according to SimilarWeb for the period 2022–2023 showed that leading players are actively investing in their own sites and content. Among the leaders are AdvancedMD (over 96 million visits), Optum (88 million), 3M Codefinder (44 million), Nuance Clintegrity (11 million) and Carepatron (2.3 million). Such figures for the B2B segment are impressive – these are tens of millions of specialists and administrators interacting with the brand through digital channels.
At the same time, the traffic structure shows a clear trend: 45% of visitors come directly, 38% through organic search, and only 2% through email. Banner ads play almost no role — their share is less than 0.2%. This means that in the CAC industry, the main resource is trust and reputation, not paid advertising.
Companies offer their clients not only products, but also knowledge. For example, Optum Health Education has its own platform of free webinars and conferences, where specialists study new coding standards. 3M Codefinder actively speaks at national forums, and Nuance is developing a series of online courses for auditors. This approach forms a professional community around the brand, which then becomes an ambassador for the product.
Another trend is educational marketing. Instead of classic advertising, companies publish analytics, cases, research results, mailing lists with ICD updates or changes in HIPAA. As a result, content becomes the main channel of communication: the more useful the material, the more loyalty from the community.
In 2024–2025, according to experts, clinical coding marketing will be even more deeply integrated with educational platforms – joint programs for doctors and IT specialists, AI coding courses, billing simulators will appear. Companies that can turn training into an element of their ecosystem will gain the greatest competitive advantage.
The modern CAC market stands at the intersection of several major processes: technological evolution, regulatory changes and a rethinking of the very role of data in medicine. If 2015 can be called the stage of digitalization of hospitals, then 2025 is already the era of intellectualization of medical processes, where data is not just collected, but also actively analyzed.
Among the dozens of trends noted by analysts Mordor Intelligence and Precedence Research, the most influential can be distinguished – they are the ones that will shape the appearance of the industry by 2031:
Autonomous Coding. A new generation of systems based on Clinical Language Understanding (CLU) is able to independently determine the code without human intervention, relying on understanding the context of the text.
Cloud architecture. Web and cloud solutions have replaced local servers, providing flexibility, security and real-time updates.
Machine learning and image recognition. Algorithms now analyze not only text data, but also the results of visual diagnostics, which expands the boundaries of coding.
COVID-19 as a catalyst. The pandemic has accelerated automation – the volume of reports and tests has increased tenfold, and manual coding has become unrealistic.
Investment in R&D. Market leaders are increasing spending on research into the accuracy and speed of systems, forming a new standard of quality.
These trends do not just describe the future – they are already being implemented. For example, autonomous coding is being implemented by AQuity Solutions and CodaMetrix, and companies like Fathom have raised tens of millions of dollars in investments specifically for the development of CLU algorithms.
Another important direction is adaptation to ICD-11. The transition to the new classification began in 2022 and is still ongoing. It contains more than 55 thousand codes, so automation is becoming critically necessary: a person is physically unable to process such volumes.
In a broader sense, the clinical coding market is becoming a testing ground for testing the integration of AI into medicine. Models are tested here, which are then used in diagnostics, pharmacology, and analytics. It is through this industry that the main evolutionary path passes – from “manual data collection” to full cognitive medicine, where algorithms and humans work as a single system.
Along with the development of technology, risks also increase. Medical coding is an area where any mistake can have serious consequences: from financial sanctions to a threat to the patient’s life. Therefore, each new technology is tested not only for effectiveness, but also for ethics and safety.
Among the most important challenges that determine the future of the market, experts name several key areas:
The first is the protection of personal data. All systems working with AI must comply with the requirements of HIPAA in the US or GDPR in the EU. This means not only database encryption, but also access control, logging of actions and anonymization of patients.
The second is interoperability. Each hospital may have its own software, and it is difficult to ensure seamless integration between them. Companies develop APIs, gateways, middleware layers to connect coding to any system.
The third is the human factor. Some staff fear that automation will replace their positions. In fact, AI does not eliminate coders – it changes their role: now they become quality analysts who control the accuracy of algorithms and train models.
The fourth challenge is training models. For high accuracy, large data sets are required: patient histories, rejected bills, real errors. However, in medicine, access to such data is limited, so companies are looking for ways to create “ethical” sets – synthetic or depersonalized.
The fifth is the transition to ICD-11. This is not just an update to the code base, but a complete overhaul of the system. Algorithms trained on ICD-10 must be recalibrated, which takes time and money.
All of these factors create tension, but at the same time they drive the market forward. Each obstacle is a growth point: the more a company invests in security, the more trust it gains from hospitals and regulators. As a result, a new industry standard is being formed for 2025 — “Responsible AI in Healthcare,” which combines ethical principles, legal compliance, and technical reliability.
What we are seeing in the clinical coding market today is not just a technological evolution, but a systemic change in the very logic of healthcare. Previously, coding was perceived as an administrative function, but now it is becoming the basis for managing medical data that affects financial, clinical and research decisions.
If we look at the global dynamics, three key levels of development of the industry are clearly visible:
The first is data standardization, when all countries gradually switch to a single ICD-11 system, and hospitals implement electronic medical records. This creates the basis for data integration between different institutions and regions.
The second is process automation, when CAC systems take on routine tasks: error checking, code assignment, report generation. At the same time, a person moves into the role of controller and mentor of algorithms.
The third level is the analytical transformation, when the results of coding become the basis for predictive analytics: identifying trends in morbidity, analyzing treatment effectiveness, and financial planning of clinics.
In the US, this transformation is almost complete: leading companies have integrated their products into health insurance systems, and hospitals work with AI solutions on a daily basis. In Europe, the process is slower due to regulatory restrictions, but it is more sustainable. Here, the implementation of AI is accompanied by legislative control and close cooperation with governments.
Asia, Australia, and the Middle East are only gaining momentum, but these are the regions that demonstrate the highest growth rates. For example, projects in Saudi Arabia, Singapore, India, and the UAE show how public investments can create a fully digital infrastructure in a few years.
If you combine all this data, it becomes obvious: clinical coding ceases to be an auxiliary segment and turns into a key infrastructure component of the healthcare system. It is through it that the information is collected, standardized and interpreted, which then goes to scientific research, insurance companies and government think tanks.
The high level of investment — more than $20 billion in just 15 leading companies — shows that business understands the scale of this transformation. In parallel, a new type of partnership is being formed between technology corporations, hospitals and educational institutions: clinics are becoming testing grounds, and universities are training centers for AI coders.
Another important trend is the emergence of mixed coding models, when AI performs 80% of the work, and a person checks the most complex cases. This allows you to reduce costs, speed up information processing and increase accuracy. According to expert forecasts, by 2030 such hybrid systems will become standard in most countries.
Thus, clinical coding is becoming the “language of medicine”, a universal interface between the doctor, the patient and the healthcare system. It determines how information about a person’s health will be stored, interpreted, and used for further decisions.
Despite its rapid growth, the clinical coding market has not yet reached its limit. The next decade will be a time of integration of artificial intelligence with other areas of HealthTech – electronic charts, telemedicine, genetic research and image analytics. All this will turn coding into a real “nerve center” of digital medicine.
Leading companies are already betting on generative AI – systems that can not only analyze, but also formulate new medical conclusions. For example, such algorithms can help a doctor write medical reports, automatically generate codes and offer recommendations based on large data sets. This increases the efficiency of staff work and reduces the number of human errors.
Another strategic direction is localization and personalization. Although international standards (such as ICD-11) unify the system, local adaptations remain necessary. In the future, “smart templates” will appear for different regions and types of medical institutions, which will take into account local protocols, languages, and insurance rules.
Integration with insurance APIs will also be of great importance. As insurance companies automate the verification of requests, CAC platforms must provide data in a unified format, which will reduce delays in payment. Such integrations are already being tested in the US and are gradually being implemented in the EU.
An equally important area is the educational transformation. Medical coding specialists are becoming data analysts, and they need new skills: working with algorithms, evaluating AI results, understanding statistical models. Therefore, companies offering software are simultaneously launching training programs – certifications, courses, online platforms.
It is worth noting the emergence of new models of cooperation between public and private structures. Governments are increasingly acting as customers of CAC solutions for national health systems, as happened in Saudi Arabia, where more than 450 hospitals have switched to automated coding. Such projects have a huge effect of scale and set standards for the region.
If we estimate the potential for 2025–2031, the market could double or even triple in size. The main drivers will remain:
the rapid adoption of AI across all areas of medicine;
the global need to reduce administrative costs;
the growing demand for unified data for scientific research and forecasting.
All this means that clinical coding is no longer just a part of documentation – it is becoming the infrastructure of future medicine, on which analytics, diagnostics, and patient flow management will be based.
Clinical coding is the invisible engine that powers the entire healthcare ecosystem. Without it, insurance payments, disease statistics, budget planning, and even basic research are impossible. But today, this engine is undergoing the greatest transformation in its history.
Artificial intelligence is transforming coding from a manual process into an autonomous, self-learning system that works with thousands of data sources in real time. Cloud technologies are removing scalability limitations, and standards like ICD-11 are creating a common language for the whole world.
In the coming years, medicine will finally move from the “human enters data” model to the “algorithm analyzes and suggests solutions” model. And while this raises concerns about replacing people, in fact, the new system is creating new professions — data analysts, AI curators, algorithm auditors. People are not disappearing, they are rising to a new level of control and understanding.
The clinical coding market will become one of the most stable and valuable sectors of HealthTech by 2031. Its members, from giants like 3M and Optum to young startups like Carepatron and Fathom, are shaping an ecosystem where data is transformed into knowledge, and knowledge into health.
In short, the future of medicine is here. It begins not in the operating room or the lab, but in the lines of code that create invisible clinical coding systems every day. They are the ones that determine how accurately we understand disease—and how effectively we can combat it.
